Doug Long on the Changes He Has Seen and Retirement | PBMI 2024
The IQVIA vice president of industry relations and his talks featuring rapid-fire delivery of voluminous slide decks is a familiar figure in managed care circles. He is retiring in May 2025.
Doug Long, MBA, vice president of industry relations at IQVIA, discussed changes in the pharmaceutical industry over the course of his decades-long career after he gave the keynote address at the 2024 Annual National Conference in Orlando, Florida, last week.
Some of the major changes: The shift in spending from traditional to specialty drugs and from prescriptions being dispensed largely at retail drugstores to shipping via mail order pharmacies.
Long started with IMS Health in 1989. IQVIA is the company created by the merger of IMS Health and Quintiles, a contract research organization, in 2016.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
